Cargando…

Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience

OBJECTIVES: To evaluate how accurate a 12-core transrectal biopsy derived low-risk prostate cancer diagnosis is for an active surveillance programme by comparing the histological outcome with that from confirmatory transperineal sector biopsy. SUBJECTS AND METHODS: The cohort included 166 men diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosco, Cecilia, Cozzi, Gabriele, Kinsella, Janette, Bianchi, Roberto, Acher, Peter, Challacombe, Benjamin, Popert, Rick, Brown, Christian, George, Gincy, Van Hemelrijck, Mieke, Cahill, Declan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cancer Intelligence 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854226/ https://www.ncbi.nlm.nih.gov/pubmed/27170833 http://dx.doi.org/10.3332/ecancer.2016.633

Ejemplares similares

Serial transperineal sector prostate biopsies: impact on long-term erectile dysfunction
por: Chong, James JY, et al.
Publicado: (2016)

Brief behavioural intervention, delivered as standard care, to support physical activity engagement in men with prostate cancer: a pilot study protocol
por: Fox, Louis, et al.
Publicado: (2018)

Developing a consensus statement for psychosocial support in active surveillance for prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2022)

Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
por: Beckmann, Kerri, et al.
Publicado: (2021)

Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2021)

Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2022)

Research engagement among black men with prostate cancer
por: Toms, Charlotte, et al.
Publicado: (2016)

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2017)

Effect of a brief physical activity-based presentation by a former patient for men treated with radical prostatectomy for prostate cancer: a mixed methods pilot study
por: Fox, Louis, et al.
Publicado: (2020)

Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices
por: Kinsella, Netty, et al.
Publicado: (2018)

The need for research methodology to improve acceptability of long-term surveillance for cancer
por: Kinsella, Netty, et al.
Publicado: (2021)

Our first month of delivering the prostate cancer diagnostic pathway within the limitations of COVID‐19 using local anaesthesia transperineal biopsy
por: Popert, Rick, et al.
Publicado: (2020)

The incidence and prevalence of upper tract urothelial carcinoma: a systematic review
por: Soualhi, Ahmed, et al.
Publicado: (2021)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy
por: Damani, Arees, et al.
Publicado: (2016)

Laparoscopic radical prostatectomy outcome data: how should surgeon’s performance be reported? A retrospective learning curve analysis of two surgeons
por: Mason, Sarah, et al.
Publicado: (2016)

Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic?
por: George, Gincy, et al.
Publicado: (2023)

Magnetic Resonance Imaging–Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer
por: Jayadevan, Rajiv, et al.
Publicado: (2019)

Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
por: Russell, Beth, et al.
Publicado: (2020)

Recent Advances in Systematic and Targeted Prostate Biopsies
por: Devetzis, Konstantinos, et al.
Publicado: (2021)

Your next clinical cancer research project: preparation in a multidisciplinary environment is key
por: Van Hemelrijck, Mieke, et al.
Publicado: (2017)

How does COVID‐19 impact treatment decision‐making for clinicians in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2020)

Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?
por: Osses, Daniël F., et al.
Publicado: (2020)

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden
por: George, Gincy, et al.
Publicado: (2023)

Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022)

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
por: Simmons, C., et al.
Publicado: (2009)

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study
por: Wong, Kathie, et al.
Publicado: (2023)

Factors that influence patients’ views on treatment decision-making in localised kidney cancer
por: Beyer, Katharina, et al.
Publicado: (2021)

Is there any association between prostate-specific antigen screening frequency and uptake of active surveillance in men with low or very low risk prostate cancer?
por: Beckmann, Kerri, et al.
Publicado: (2019)

Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance
por: Salguero, Joseba, et al.
Publicado: (2021)

Real World Evidence: A Quantitative and Qualitative Glance at Participant Feedback from a Free-Response Survey Investigating Experiences of a Structured Exercise Intervention for Men with Prostate Cancer
por: Fox, L., et al.
Publicado: (2017)

Is there a role for IGF‐1 in the development of second primary cancers?
por: Shanmugalingam, Thurkaa, et al.
Publicado: (2016)

Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
por: White, Benjamin E., et al.
Publicado: (2022)

Confirmatory Composite Analysis
por: Schuberth, Florian, et al.
Publicado: (2018)

Hospitals Considered with Reference to Their Construction, &c.
Publicado: (1866)

Hospitals Considered with Reference to Their Construction, &c.
Publicado: (1866)

The association between circulating IGF1, IGFBP3, and calcium: results from NHANES III
por: Van Hemelrijck, Mieke, et al.
Publicado: (2015)

Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
por: Bosco, Cecilia, et al.
Publicado: (2015)

Risk of cardiovascular disease following gonadotropin‐releasing hormone agonists vs antagonists in prostate cancer: Real‐world evidence from five databases
por: George, Gincy, et al.
Publicado: (2020)

Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review
por: Chen, Miaoqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1dmreeujpku10bbmthlqbf1ok5